Literature DB >> 15270730

The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins.

Graham A Auger1, Brenda M Smith, James E Pease, Michael D Barker.   

Abstract

The complement fragment C5a is a potent leucocyte chemoattractant and activator, mediating its effects through a G-protein-coupled receptor. Whilst the C-terminal domain of this receptor has been shown to be essential for receptor desensitization and internalization, it is not known which domains couple to the receptor's heterotrimeric G proteins. In this report we have used a membrane translocating sequence (MTS) to examine the effects of the four intracellular domains of the human C5a receptor (C5aR) on the receptor's signalling via G(alphai) family heterotrimeric G proteins in intact RBL-2H3 cells. The results indicate that all of the intracellular domains couple to downstream signalling, with the proximal region of the C terminus being a major binding site and intracellular loop 3 playing a role in G protein activation or receptor desensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270730      PMCID: PMC1782523          DOI: 10.1111/j.1365-2567.2004.01919.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.

Authors:  D Bock; U Martin; S Gärtner; C Rheinheimer; U Raffetseder; L Arseniev; M D Barker; P N Monk; W Bautsch; J Köhl; A Klos
Journal:  Eur J Immunol       Date:  1997-06       Impact factor: 5.532

Review 2.  The many faces of G protein signaling.

Authors:  H E Hamm
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

Review 3.  G protein beta gamma subunits.

Authors:  D E Clapham; E J Neer
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

Review 4.  Chemoattractant signaling and leukocyte activation.

Authors:  G M Bokoch
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

5.  Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.

Authors:  J Turkson; D Ryan; J S Kim; Y Zhang; Z Chen; E Haura; A Laudano; S Sebti; A D Hamilton; R Jove
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

6.  Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor.

Authors:  M Rojas; S Yao; Y Z Lin
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

7.  Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain.

Authors:  N Naik; E Giannini; L Brouchon; F Boulay
Journal:  J Cell Sci       Date:  1997-10       Impact factor: 5.285

8.  C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.

Authors:  P N Monk; J E Pease; M D Barker
Journal:  Biochem Mol Biol Int       Date:  1994-01

9.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors:  P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

10.  Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence.

Authors:  Y Z Lin; S Y Yao; R A Veach; T R Torgerson; J Hawiger
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

View more
  1 in total

Review 1.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.